Table 4.
Group Abbreviation | CK (U/L) | CK-MB (U/L) | LDH (U/L) |
---|---|---|---|
S-DM-CUS-AMI vs. | |||
AMI-C | 0.6544 | 0.7968 | 0.3067 |
DM-C | 0.5220 | 0.0021 | 0.0022 |
DM-AMI-C | 0.0022 | 0.0039 | 0.0049 |
CUS-DM-CUS-AMI vs. | |||
AMI-C | 0.1244 | 0.0630 | 0.7491 |
DM-C | 0.1098 | 0.0021 | 0.0033 |
DM-AMI-C | 0.0022 | 0.0022 | 0.0022 |
S-DM-CUS-AMI | 0.0348 | 0.0613 | 0.0409 |
S-DM-CUN-AMI vs. | |||
AMI-C | 0.0033 | 0.0026 | 0.0106 |
DM-C | 0.0026 | 0.0047 | 0.3067 |
DM-AMI-C | 0.0022 | 0.0021 | 0.0022 |
S-DM-CUS-AMI | 0.0033 | 0.0021 | 0.0022 |
CUN-DM-CUN-AMI vs. | |||
AMI-C | 0.0022 | 0.0021 | 0.0022 |
DM-C | 0.0022 | 0.1754 | 0.0215 |
DM-AMI-C | 0.0022 | 0.0021 | 0.0022 |
CUS-DM-CUS-AMI | 0.0022 | 0.0021 | 0.0022 |
S-DM-CUN-AMI | 0.0022 | 0.0032 | 0.0073 |
Abbreviations: CK, creatine kinase; CK-MB, creatine kinase-MB; LDH, lactate dehydrogenase; N, normal; C, control; AMI, acute myocardial infarction; DM, diabetes mellitus; S, saline; CUS, curcumin solution in a dose of 200 mg/kg bw; CUN200, curcumin nanoparticles solution in a dose of 200 mg/kg bw.